Skip to main content
. Author manuscript; available in PMC: 2014 Aug 26.
Published in final edited form as: Crit Care Med. 2009 May;37(5):1605–1611. doi: 10.1097/CCM.0b013e31819da8c7

Figure 2.

Figure 2

Kaplan-Meier survival curves for all intensive care unit (ICU) human immunodeficiency virus (HIV)-infected patients stratified according to the use of antiretroviral therapy. The survival of patients who began antiretroviral therapy (ART) during ICU stay (green) was significantly different from patients without ART during ICU stay (p = 0.004) (black). The survival of patients with previous and continuous use of ART at the ICU (red) was not different from HIV-infected patients without antiretroviral therapy during ICU stay (p = 0.39).